Treatment of early non-response in patients with schizophrenia: assessing the efficacy of antipsychotic dose escalation

BACKGROUND: Early non-response to antipsychotic treatment in patients with schizophrenia has been shown in multiple studies to predict poor response at short-term trial endpoint. Therefore, strategies to address the challenge of non-improvement early in the course of treatment are needed. A novel tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Loebel, Antony, Citrome, Leslie, Correll, Christoph U., Xu, Jane, Cucchiaro, Josephine, Kane, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628370/
https://www.ncbi.nlm.nih.gov/pubmed/26521019
http://dx.doi.org/10.1186/s12888-015-0629-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628370/
https://www.ncbi.nlm.nih.gov/pubmed/26521019
http://dx.doi.org/10.1186/s12888-015-0629-0

Ejemplares similares